Biotech startups in Durham, North Carolina
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Ramona | Durham | Series A | $25.0M | 2026-09-22 |
| Avalo | Durham | Series A | $11.0M | 2025-03-06 |
| Polaris Quantum Biotech | Durham | Seed | $2.1M | 2021-08-10 |
| Basking Biosciences | Durham | Series A | $55.0M | 2024-01-30 |
| inSomaBio | Durham | Seed | $2.7M | 2025-10-20 |
| Elo Life Systems | Durham | Series A | $20.5M | 2024-01-24 |
| Clinetic | Durham | Series A | $5.0M | 2023-08-08 |
| Amphora Discovery | Durham | Series E | $4.4M | 2006-02-24 |
8 rows of the CSV in 5 of its 18 columns.
- The 46 biotech startups in Durham, North Carolina have raised $1.3B in total.
- 4 of them closed their most recent round in the last 12 months, $31.0M combined.
- The largest of those rounds is Ramona's $25.0M Series A, dated September 2026.
- The most recent is Toggle Bio's $200K seed round on 6 October 2026.
- National Science Foundation is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 38 companies (83%).
- 20% were founded in 2020 or later; the median founding year is 2014.
- The most common team size is 11 to 50 employees (50% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
8 of 46| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Ramona | Ramona develops high-throughput microscopy tools for biology labs. | Artificial intelligence | Series A | $25.0M | 2026-09-22 | $59.7M | National Science Foundation, National Institutes of Health, E14 Fund +1 | 11 to 50 | 2017 |
| inSomaBio | inSomaBio combines biology and materials science to address challenges in tissue engineering and regenerative medicine. | Biotech | Seed | $2.7M | 2025-10-20 | $8.0M | Y Combinator, National Science Foundation, Asymmetry Ventures +1 | 11 to 50 | 2018 |
| Avalo | Avalo applies AI and evolutionary methods to plant biotechnology for a more sustainable food system. | Artificial intelligence | Series A | $11.0M | 2025-03-06 | $14.9M | SOSV, SOSV SF & NY (Fka IndieBio), Alexandria Venture Investments +2 | 11 to 50 | 2020 |
| Basking Biosciences | Basking Biosciences commercializes technologies developed at Duke University and Ohio State University. | Biotech | Series A | $55.0M | 2024-01-30 | $62.3M | Insight Partners, Rev1 Ventures, ARCH Venture Partners +1 | 1 to 10 | 2019 |
| Elo Life Systems | Elo Life Systems is a biotechnology company that studies how food supports human health and wellness. | Biotech | Series A | $20.5M | 2024-01-24 | $56.5M | Novo Holdings, Alexandria Venture Investments, DCVC Bio +2 | 11 to 50 | 2006 |
| Clinetic | Clinetic provides health software and technology services. | Biotech | Series A | $5.0M | 2023-08-08 | $11.4M | Sopris Capital Associates | 11 to 50 | 2017 |
| Polaris Quantum Biotech | Polaris Quantum Biotech combines quantum computing, AI, and precision medicine to design new drugs. | Artificial intelligence | Seed | $2.1M | 2021-08-10 | $2.1M | OurCrowd | 1 to 10 | 2020 |
| Data Driven Bioscience | Data Driven Bioscience provides integrated kits and software for clinical cancer genomics and diagnosis. | Biotech | Seed | $120K | 2018-08-20 | Y Combinator, IT-Farm | 1 to 10 | 2018 |
Table 1. Biotech startups in Durham, North Carolina: the 8 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 46.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ramona | Ramona develops high-throughput microscopy tools for biology labs. | Artificial intelligence | Series A | $25.0M | 2026-09-22 | $59.7M | National Science Foundation, National Institutes of Health, E14 Fund +1 | 11 to 50 | 2017 |
Table 2. Biotech startups in Durham, North Carolina: the 1 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | National Science Foundation | Entrepreneurship program | Alexandria, United States | 2 | 4% | 1 | Ramona |
| 2 | Alexandria Venture Investments | Venture capital firm | Pasadena, United States | 2 | 4% | ||
| 3 | Y Combinator | Startup accelerator | Mountain View, United States | 2 | 4% | ||
| 4 | One North Carolina Small Business Program | Government investment office | Raleigh, United States | 1 | 2% | 1 | Ramona |
| 5 | National Institutes of Health | Entrepreneurship program | Bethesda, United States | 1 | 2% | 1 | Ramona |
| 6 | E14 Fund | Micro VC fund | Cambridge, United States | 1 | 2% | 1 | Ramona |
| 7 | SOSV SF & NY (Fka IndieBio) | Venture capital firm | San Francisco, United States | 1 | 2% | ||
| 8 | SOSV | Venture capital firm | Princeton, United States | 1 | 2% | ||
| 9 | Better Ventures | Venture capital firm | Oakland, United States | 1 | 2% | ||
| 10 | At One Ventures | Venture capital firm | San Francisco, United States | 1 | 2% | ||
| 11 | OurCrowd | Venture capital firm | Jerusalem, Israel | 1 | 2% | ||
| 12 | Insight Partners | Private equity firm | New York, United States | 1 | 2% | ||
| 13 | ARCH Venture Partners | Venture capital firm | Chicago, United States | 1 | 2% | ||
| 14 | Rev1 Ventures | Corporate venture arm | Columbus, United States | 1 | 2% | ||
| 15 | Broadview Ventures | Venture capital firm | Boston, United States | 1 | 2% |
Table 3. Biotech startups in Durham, North Carolina: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 38 | 83% | $1.2B |
| Software | 8 | 17% | $183.7M |
| Artificial intelligence | 3 | 7% | $76.7M |
| Hardware | 3 | 7% | $63.2M |
| Fintech | 2 | 4% | $760K |
Table 4. Biotech startups in Durham, North Carolina by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Seed | 14 | 30% | $810K |
| Series A | 15 | 33% | $15.8M |
| Series B | 10 | 22% | $6.5M |
| Series C | 3 | 7% | $37.1M |
| Series D+ | 4 | 9% | $26.0M |
Table 5. Biotech startups in Durham, North Carolina by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 25% | $200K |
| September 2026 | 2 | 50% | $25.8M |
| April 2026 | 1 | 25% | $5.0M |
Table 6. Biotech startups in Durham, North Carolina: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 4 | 9% | $31.0M |
| 2025 | 5 | 11% | $346.7M |
| 2024 | 3 | 7% | $79.0M |
| 2023 | 4 | 9% | $17.6M |
| 2022 | 1 | 2% | $5.4M |
| 2021 | 5 | 11% | $104.6M |
Table 7. Biotech startups in Durham, North Carolina by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 3 | 7% |
| 2020 to 2022 | 6 | 14% |
| 2015 to 2019 | 12 | 27% |
| 2010 to 2014 | 7 | 16% |
| Before 2010 | 16 | 36% |
Table 8. Biotech startups in Durham, North Carolina by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 17 | 39% |
| 11 to 50 | 22 | 50% |
| 51 to 100 | 3 | 7% |
| 501 to 1,000 | 2 | 5% |
Table 9. Biotech startups in Durham, North Carolina by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Durham, North Carolina. On 16 November 2026 that is 46 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 8 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 46 rows: 4 have no round amount, 0 no city and 9 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Durham, North Carolina are on the list?
- 46, in the file dated 16 November 2026. 4 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 46 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.